Australian and New Zealand Governments Agree to Proceed with the Joint Regulatory Agency for Therapeutic Products
This item is not available in full-text via OUR Archive.
If you are the author of this item, please contact us if you wish to discuss making the full text publicly available.
Cite this item:
Jennifer Moore "Australian and New Zealand Governments Agree to Proceed with the Joint Regulatory Agency for Therapeutic Products: Letter to the Editor" (2011) 19 JLM 272.
Permanent link to OUR Archive version:
http://hdl.handle.net/10523/6172
Abstract:
In 2011, the Australian and New Zealand governments announced their decision to proceed with a joint scheme for the regulation of therapeutic products such as medicines, medical devices and new medical interventions. Eventually, the joint arrangements will be administered by a single regulatory entity: the Australian and New Zealand Therapeutic Products Agency (ANZTPA). The rationale for establishing ANZTPA is based on public health and economic principles. This paper explores the strengths and weaknesses of the proposed therapeutic products legislation, which will repeal the Medicines Act (NZ) - the Therapeutic Products and Medicines Bill.
Date:
2011
Publisher:
Thomson Reuters
Keywords:
medicines; medical devices; therapeutic products; medicines legislation
Research Type:
Other
Languages:
English
Collections
- Law Collection [511]
- Other Type [42]